Donisi Health is a MedTech company providing in-home health detection solutions for congestive heart failure (CHF) and chronic-disease patients.

SOLUTION

Donisi enables a user-friendly pre-emptive approach to cardiac and pulmonary health monitoring in the home, helping to optimize the continuum of care for patients with CHF and other chronic diseases and avoid unnecessary rehospitalization.

OVERVIEW

Donisi is helping patients with Congestive Heart Failure (CHF) and other chronic cardiopulmonary diseases, freeing them to focus on living their life to the fullest, by monitoring the patient’s health daily to support timely detection of changes in lung fluid content (indicating heart failure exacerbation) and more, thereby avoiding unnecessary rehospitalization. Based on Donisi’s FDA-cleared technology, and backed by 11 granted patents, Donisi’s contact-free health detection works free from wires, wearables, and patches. Our patented AI-based system detects and analyzes multiple health bio-indicators simultaneously, delivering clinically meaningful insights and notifications of changes in key health indicators. Donisi has the only clinically validated contact-free technology that can remotely detect signs of pulmonary congestion and additional parameters key for heart failure exacerbation detection in the home.

2021 ACHIEVEMENTS

- FDA Clearance: Gili Pro BioSensor 

- 11 Granted Patents 

- BIRD Grant Recipient - Partnership with Dell Technologies 

- Winner, MEDinISRAEL 2021, Startup Innovation Competition 

- Winner, Future Unicorn, E&T Innovation 

- Winner, Innovations in Cardiac Intervention (ICI), 2021

Follow on LinkedIn 

Visit Website 

Biofourmis Care is a holistic, customizable, end-to-end solution that delivers virtual care to patients with acute, post-acute, and chronic medical conditions in the comfort of their own homes. Medical-grade wearables allow for continuous, real-time monitoring and patient-specific notifications enable caregivers to deliver exceptional care to patients anywhere. Our 24/7 virtual clinical care team, staffed by health navigators, nurses, and physicians can monitor and manage patients with acute or chronic medical conditions. Biofourmis Care is powered by the FDA-cleared Biovitals Analytics Engine and Biovitals Index which utilizes artificial intelligence and machine learning to interpret and analyze physiological signals, delivering personalized patient insight. Additional Biofourmis Care features and services include:

Biofourmis brings the right care to every person, no matter where they are. The company’s AI-driven solutions provide people everywhere with connected access to hospital-level services, virtual provider networks for remote care, and life-changing clinical trials—all without leaving their homes. Trusted by leading health systems, life science companies and patients alike, Biofourmis’ connected platform improves patient outcomes, accelerates drug development, and closes critical gaps in care—ultimately making science smarter, healthcare simpler, and patients healthier.

-

Donisi's Gili Pro BioSensor is the only solution to receive FDA clearance for the simultaneous detection of cardiac and pulmonary health biomarkers through the use of light waves (nano-vibration motion detection).

Biofourmis Care is a remote patient management solution that can be deployed and scaled across health systems as an enabler or as a provider of care. 

One platform - The Biofourmis platform can support patients across the care continuum, from acute and post-acute conditions to complex chronic diseases.

End-to-End Solution - From patient onboarding, training, delivery logistics, clinical monitoring, billing, and technical support, Biofourmis Care offers every component needed to delivers remote patient care.

FDA-Cleared Analytics Engine - Machine learning model that creates a personalized baseline for individual patients based on continuous physiological signals and uses multiparametric data to derive clinical insights. Shown to significantly reduce false positive notifications in both acute and post-acute care settings.